
Keywords: Phospholipid asymmetry; Lysophosphatidic; Platelet-activating factor; Phosphoinositides; PLRP2; Phospholipase B; 2-AG; 2-arachidonoyl-glycerol; ATX; autotaxin; cPLA2; cytosoluble phospholipase A2; DAG; diacylglycerol; ECs; endocannabinoids; IP3; inositol